These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11255679)

  • 1. Gene therapy: development of immunostimulatory treatments for cancer.
    Gilligan MG; Knox PG; Searle PF
    Biotechnol Genet Eng Rev; 2000; 17():497-529. PubMed ID: 11255679
    [No Abstract]   [Full Text] [Related]  

  • 2. Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine.
    Block MS; Suman VJ; Nevala WK; Kottschade LA; Creagan ET; Kaur JS; Quevedo JF; McWilliams RR; Markovic SN
    Melanoma Res; 2011 Oct; 21(5):438-45. PubMed ID: 21697748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral vectors for gene transfer into antigen presenting cells.
    Monahan SJ; Salgaller ML
    Curr Opin Mol Ther; 1999 Oct; 1(5):558-64. PubMed ID: 11249662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When transgenes shape immunity: cancer immune-gene therapy.
    Bonini C; Parmiani G
    J Gene Med; 2012 Jun; 14(6):384-5. PubMed ID: 22736622
    [No Abstract]   [Full Text] [Related]  

  • 5. Dendritic cells: emerging roles in tumor immunotherapy.
    Buchsel PC; DeMeyer ES
    Clin J Oncol Nurs; 2006 Oct; 10(5):629-40. PubMed ID: 17063617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostimulatory DNA sequences and cancer therapy.
    Weiner GJ
    Springer Semin Immunopathol; 2000; 22(1-2):107-16. PubMed ID: 10944805
    [No Abstract]   [Full Text] [Related]  

  • 7. Dendritic cells and cytokines in immune rejection of cancer.
    Ferrantini M; Capone I; Belardelli F
    Cytokine Growth Factor Rev; 2008 Feb; 19(1):93-107. PubMed ID: 18054517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting dendritic cells with antigen-containing liposomes: antitumour immunity.
    Altin JG; van Broekhoven CL; Parish CR
    Expert Opin Biol Ther; 2004 Nov; 4(11):1735-47. PubMed ID: 15500402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer vaccines based on dendritic cells loaded with tumor-associated antigens.
    Burdin N; Moingeon P
    Cell Biol Toxicol; 2001; 17(2):67-75. PubMed ID: 11499697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccines: dream, reality, or nightmare?
    Biagi E; Rousseau RF; Yvon E; Vigouroux S; Dotti G; Brenner MK
    Clin Exp Med; 2002 Nov; 2(3):109-18. PubMed ID: 12463196
    [No Abstract]   [Full Text] [Related]  

  • 11. Combinatorial vaccine strategies and the use of molecular arrays to characterize T-cell activation.
    Schlom J; Palena C; Greiner JW; Tsang KY; Grosenbach DW; Sabzevari H; Gulley JL; Arlen PM; Kass E; Hodge JW
    Dev Biol (Basel); 2004; 116():27-47. PubMed ID: 15603182
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer vaccine strategies get bigger and better.
    de Gruijl TD; Curiel DT
    Nat Med; 1999 Oct; 5(10):1124-5. PubMed ID: 10502808
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization delivered by lentiviral vectors for cancer and infectious diseases.
    Hu B; Tai A; Wang P
    Immunol Rev; 2011 Jan; 239(1):45-61. PubMed ID: 21198664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loading DCs with Ag.
    Vari F; Hart DN
    Cytotherapy; 2004; 6(2):111-21. PubMed ID: 15203987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programming the next generation of dendritic cells.
    Carroll RG; June CH
    Mol Ther; 2007 May; 15(5):846-8. PubMed ID: 17446871
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted cancer therapy: dendritic cell metabolism.
    Gray J; Chiappori A
    Ther Deliv; 2011 Feb; 2(2):133-6. PubMed ID: 22833938
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.
    Jinushi M; Hodi FS; Dranoff G
    Immunol Rev; 2008 Apr; 222():287-98. PubMed ID: 18364009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM-CSF-based cancer vaccines.
    Dranoff G
    Immunol Rev; 2002 Oct; 188():147-54. PubMed ID: 12445288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides.
    Kavanagh B; Ko A; Venook A; Margolin K; Zeh H; Lotze M; Schillinger B; Liu W; Lu Y; Mitsky P; Schilling M; Bercovici N; Loudovaris M; Guillermo R; Lee SM; Bender J; Mills B; Fong L
    J Immunother; 2007 Oct; 30(7):762-72. PubMed ID: 17893568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell response to tumor antigens and its therapeutic use in cancer patients.
    Parmiani G; Castelli C; Dalerba P; Rivoltini L
    Adv Exp Med Biol; 2001; 495():403-10. PubMed ID: 11774601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.